已收录 268921 条政策
 政策提纲
  • 暂无提纲
Nocturia: Finding an Identity
[摘要] Nocturia is a condition that has a tremendous impact on a patient’s health and wellbeing. Getting up 2 or more times a night to urinate fragments sleep, preventing deep, restorative stages of the sleep cycle. With safer and more effective therapies, nocturia is a treatable condition that no longer should be overlooked. The simplicity of directly targeting the cause of nocturia, the overproduction of urine (ie, nocturnal polyuria) should be considered. Noctiva™ (desmopressin acetate) nasal spray (Avadel Pharmaceuticals plc, Chesterfield, MO), a novel FDA-approved microdose desmopressin nasal spray, can reduce nighttime urine production and potentially mitigate the potential harm of nocturia.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 基础医学
[关键词] LUTS;Nocturia;BPH;Desmopressin acetate;Quality of life [时效性] 
   浏览次数:12      统一登录查看全文      激活码登录查看全文